Sign in to view content

Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2018

Related

Part 2: Implementing Clinical Trials in a Retina Practice: How to Get Started and Recruit Successfully (Part 2 of 3)
Arshad M. Khanani, MD, MA, FASRS
Carl J Danzig, MD
On Demand Cases, Courses, and Papers
2018
Interim Safety and Efficacy Results From the Phase 1 HELIOS Trial of Sustained-Release Axitinib Implant (OTX-TKI) for NPDR
Dilsher S. Dhoot, MD
Annual Meeting Talks
2024
Outcomes of Repair of Moderately Complex Phakic Rhegmatogenous Retinal Detachment (RRD): The PRO Study (Primary Retinal Detachment Outcomes)
Edwin H. Ryan, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more